Walgreens, CVS limit sales of children’s medications amid ‘tripledemic’

Walgreens, CVS limit sales of children’s medications amid ‘tripledemic’


A sign is placed near the section for children’s medicine, Monday, Dec.19, 2022 at a Walgreens, in New York, United States.

Fatih Aktas | Anadolu Agency | Getty Images

CVS and Walgreens are limiting how many children’s pain relief medications people can buy at once amid a winter “tripledemic” of respiratory viruses, the companies said Monday.

In a statement, CVS said it is limiting the number of pain relief medications to two. Walgreens customers can buy six over-the-counter pediatric fever reducers, the company said in a statement.

“Due to increased demand and various supplier challenges, over-the-counter pediatric fever reducing products are seeing constraint across the country,” Walgreens said.

The cap applies to products bought online or at the pharmacies, the companies said.

Walmart said in a statement that although the company has seen higher demand for pediatric medication this year, it has been able to meet that demand and no purchase limits are in place.

A spokesperson for the Department of Health and Human Services said the agency had been tracking surging demand for medication.

“Every operating division across HHS is engaged and playing a pivotal role in addressing these concerns,” the spokesperson said in a statement.

In a separate statement, the Food and Drug Administration added that it can’t require companies to manufacture medications, but it is working closely with drugmakers to “understand, mitigate and prevent or reduce the impact of intermittent or increased demand of certain products.

“The FDA understands that manufacturers expect availability to continue to increase in the near future,” the statement said.

Doctors this fall saw an early surge in respiratory illnesses among young children, with babies and preschool-age kids catching the flu and other viruses, including respiratory syncytial virus, or RSV.

Several children’s hospitals in the U.S. also recently detected a severe and invasive form of strep that has killed at least 15 children in the United Kingdom since mid-September.

NEW YORK, NY – DECEMBER 19: A person purchases medicine, Monday, Dec.19, 2022 at a Walgreens, in New York, United States.

Fatih Atkas | Anadolu Agency | Getty Images

As of Monday, 78% of the inpatient beds in nearly 5,000 hospitals across the country were filled, according to data from the Department of Health and Human Services. Nearly the same percentage of intensive care beds were in use, according to the data.

According to data posted Friday by the Centers for Disease Control and Prevention, the number of people catching the flu remained high but had declined in some areas.

The agency recorded nine pediatric deaths last week, bringing the number of children who have died from the illness this season to 30. Overall, the agency estimated 150,000 flu hospitalizations and 9,300 deaths.

The respiratory viruses have hit young children hard because many remained at home after the coronavirus pandemic hit nearly three years ago, leaving their immune systems vulnerable to common illnesses, experts have said.

Valeriya Antonshchuk contributed.



Source

Eli Lilly investors shouldn’t sweat rival Novo Nordisk having the first obesity pill on sale
Health

Eli Lilly investors shouldn’t sweat rival Novo Nordisk having the first obesity pill on sale

Jim Cramer says don’t sweat Novo Nordisk’s head start over Club holding Eli Lilly in the obesity pill market. Eli Lilly stock slipped about half a percent this morning, while Novo Nordisk shares surged more than 8% after becoming the first to secure FDA approval for a GLP-1 weight-loss pill. “[Novo] got approval ahead of […]

Read More
FDA approves first GLP-1 pill for obesity from Wegovy maker Novo Nordisk
Health

FDA approves first GLP-1 pill for obesity from Wegovy maker Novo Nordisk

The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, on the outskirts of Copenhagen, Denmark, Nov. 24, 2025. Tom Little | Reuters The U.S. Food and Drug Administration on Monday approved the first-ever GLP-1 pill for obesity from Wegovy maker Novo Nordisk, a landmark decision that health experts […]

Read More
UnitedHealth Group commits to improvements after independent audit, patient backlash
Health

UnitedHealth Group commits to improvements after independent audit, patient backlash

UnitedHealthcare sign is displayed at its office building in Minnetonka, Minnesota, U.S., Dec. 11, 2025. Tim Evans | Reuters UnitedHealth Group on Friday released the first results from a sprawling independent audit of its business practices and committed to a wide range of steps to track and implement improvements in three specific areas. The health-care […]

Read More